COVID-19 and Telehealth

As the healthcare industry continues to navigate response to the COVID-19 pandemic, we are offering a series of topic-specific webinars expanding on some of the key issues. Please join us on April 30 for a dedicated conversation on telehealth, which will address changes in guidance that have occurred in response to COVID-19 and considerations for telehealth as we move into the country's re-open phase. To be covered:

  • COVID-19 Telehealth Program
    • Eligible entities
    • Benefits
    • Requirements
  • Federal and state waivers covering telehealth, including:
    • Relaxed licensure requirements
    • Relaxed HIPAA security standards
    • Relaxed rules for teleprescribing
    • Expanded reimbursement for telehealth services
    • Locations for patient and the telehealth provider
    • Use of telehealth within hospitals
    • Use of telehealth to provide MSE under EMTALA
  • Issues to still consider in telehealth:
    • State licensure/regulations that remain in effect
    • Effective informed consent
    • Applicable standard of care
    • Documentation
  • Post-COVID outlook for telehealth


Agenda: THURSDAY, APRIL 30, 2020
12:00-1:00 PM MDT


Speaker: Cory Talbot

Location: Webinar Only

Questions? Please contact Laura Squyres .

DISCLAIMER

Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.